Galecto Inc (GLTO)
0.7001
-0.02
(-2.36%)
USD |
NASDAQ |
May 03, 16:00
0.7132
+0.01
(+1.87%)
After-Hours: 20:00
Galecto 1 Year Total Returns (Daily): -59.76% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 03, 2024 | -59.76% |
May 02, 2024 | -57.32% |
May 01, 2024 | -59.99% |
April 30, 2024 | -61.62% |
April 29, 2024 | -60.13% |
April 26, 2024 | -63.29% |
April 25, 2024 | -64.98% |
April 24, 2024 | -67.43% |
April 23, 2024 | -65.99% |
April 22, 2024 | -66.94% |
April 19, 2024 | -67.00% |
April 18, 2024 | -65.05% |
April 17, 2024 | -67.42% |
April 16, 2024 | -63.83% |
April 15, 2024 | -63.83% |
April 12, 2024 | -61.96% |
April 11, 2024 | -61.53% |
April 10, 2024 | -62.22% |
April 09, 2024 | -62.40% |
April 08, 2024 | -62.57% |
April 05, 2024 | -64.65% |
April 04, 2024 | -67.34% |
April 03, 2024 | -66.56% |
April 02, 2024 | -61.56% |
April 01, 2024 | -62.57% |
Date | Value |
---|---|
March 28, 2024 | -59.38% |
March 27, 2024 | -55.73% |
March 26, 2024 | -58.08% |
March 25, 2024 | -58.79% |
March 22, 2024 | -59.38% |
March 21, 2024 | -62.27% |
March 20, 2024 | -59.33% |
March 19, 2024 | -60.42% |
March 18, 2024 | -59.77% |
March 15, 2024 | -56.03% |
March 14, 2024 | -59.76% |
March 13, 2024 | -61.87% |
March 12, 2024 | -52.55% |
March 11, 2024 | -53.54% |
March 08, 2024 | -58.37% |
March 07, 2024 | -59.95% |
March 06, 2024 | -56.56% |
March 05, 2024 | -62.90% |
March 04, 2024 | -59.92% |
March 01, 2024 | -62.73% |
February 29, 2024 | -67.11% |
February 28, 2024 | -67.97% |
February 27, 2024 | -67.61% |
February 26, 2024 | -70.18% |
February 23, 2024 | -71.76% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-84.46%
Minimum
Feb 18 2022
99.06%
Maximum
Jul 26 2023
-44.08%
Average
-59.77%
Median
Mar 18 2024
1 Year Total Returns (Daily) Benchmarks
Novo Nordisk A/S | 48.46% |
Genmab A/S | -27.42% |
Ascendis Pharma A/S | 49.85% |
Evaxion Biotech AS | -69.14% |
IO Biotech Inc | -24.68% |